I remember that blurb from Shailesh. A few years ago now. How things have changed. In those days the idea was to flog the bone powder to various companies to replace their existing mix. No-one bought it so now they've gone full circle and the previous strategy that would fail ie manufacturing is now a goer. The bit below is still true. And MNS has no line of credit in place. "One of the reasons that many start-ups fail Dr. Upreti said, is because manufacturing is capitol intense."
One of the reasons that many start-ups fail Dr. Upreti said, is because manufacturing is capitol intense. CCCCV gets around this he said by constructing the supply chain, not by actually creating the manufacturing capabilities, but instead by using existing companies in New York State.
- Forums
- ASX - By Stock
- MNS
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-67
Featured News
Add MNS (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online